argenx SE Stock Discussion

$argenx SE(ARGX.US)$ sell
$Mingteng International(MTEN.US)$ buy

$argenx SE(ARGX.US)$ $Nasdaq Composite Index(.IXIC.US)$  for long term to make high value.

it's number 4, $Amylyx Pharmaceuticals(AMLX.US)$ all time low 6.5 USD... hope you can grow and get all FDA approval... it's profitable already...
no 1. $Biogen(BIIB.US)$ all time low 2 USD
no 2. $Neurocrine Biosciences(NBIX.US)$ all time low 1.9 USD
no 3. $Biohaven(BHVN.US)$ all time low 7 USD
no5. $argenx SE(ARGX.US)$ all time low 17 USD
And it's not bubble. Of course there are also, biotech companies which are failed. But I think if it's growing into a right directio...

$Cellectar BioSciences(CLRB.US)$ Phase 2
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...

$argenx SE(ARGX.US)$
Clinical Disappointment in Phase 3 Study: Pemphigus Vulgaris (PV) and Pemphigus Foliaceus (PF)
Argenx's shares nosedived by 25% due to disappointing results from its Phase 3 study on efgartigimod subcutaneous (SC) for treating severe autoimmune diseases. The study aimed to address pemphigus vulgaris (PV) and pemphigus foliaceus (PF), causing skin blistering.
Unexpectedly Strong Impact of Corticosteroids
The primary setback was the ...

$argenx SE(ARGX.US)$ oh dear

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $argenx SE(ARGX.US)$ - up 24.6%
2. $Black Knight(BKI.US)$ - up 11.5%
3. $POSCO(PKX.US)$ - up 6.0%
4. $Aramark(ARMK.US)$ - up 1.6%
5. $Dr Reddy's Laboratories Ltd(RDY.US)$ - up 1.5%
6. $Elbit Systems(ESLT.US)$ - up 0.9%
7. $Wipro(WIT.US)$ - up 0.8%
8. $Take-Two Interactive Software(TTWO.US)$ - up 0.7...

$argenx SE(ARGX.US)$argenx Reports Positive Topline Data from ADHERE Study of VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy
$Agile Therapeutics(AGRX.US)$

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Korea Electric Power(KEP.US)$ - up 3.7%
2. $Unity Software(U.US)$ - up 2.9%
3. $NetEase(NTES.US)$ - up 1.7%
4. $Banco Santander(SAN.US)$ - up 1.5%
5. $Kellanova(K.US)$ - up 1.5%
6. $Saia(SAIA.US)$ - up 0.9%
7. $Prudential(PUK.US)$ - up 0.9%
8. $Logitech International(LOGI.US)$ - up 0...